Gain of Cellular Adaptation Due to Prolonged p53 Impairment Leads to Functional Switchover from p53 to p73 during DNA Damage in Acute Myeloid Leukemia Cells

被引:33
作者
Chakraborty, Juni [1 ]
Banerjee, Shuvomoy [1 ]
Ray, Pallab [1 ]
Hossain, Dewan Md Sakib [1 ]
Bhattacharyya, Sankar [1 ]
Adhikary, Arghya [1 ]
Chattopadhyay, Sreya [1 ]
Das, Tanya [1 ]
Sa, Gaurisankar [1 ]
机构
[1] Bose Inst, Div Mol Med, Kolkata 700054, India
关键词
CHECKPOINT KINASES CHK1; DELTA-NP73; APOPTOSIS; FAMILY; CYCLE; P63; EXPRESSION; INHIBITOR; PROTEIN; GROWTH;
D O I
10.1074/jbc.M110.122705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Tumor suppressor p53 plays the central role in regulating apoptosis in response to genotoxic stress. From an evolutionary perspective, the activity of p53 has to be backed up by other protein( s) in case of any functional impairment of this protein, to trigger DNA damage-induced apoptosis in cancer cells. We adopted multiple experimental approaches to demonstrate that in p53-impaired cancer cells, DNA damage caused accumulation of p53 paralogue p73 via Chk-1 that strongly impacted Bax expression and p53-independent apoptosis. On the contrary, when p53 function was restored by ectopic expression, Chk-2 induced p53 accumulation that in turn overshadowed p73 activity, suggesting an antagonistic interaction between p53 family members. To understand such interaction better, p53-expressing cells were impaired differentially for p53 activity. In wildtype p53-expressing cancer cells that were silenced for p53 for several generations, p73 was activated, whereas no such trend was observed when p53 was transiently silenced. Prolonged p53 interference, even in functional p53 settings, therefore, leads to the "gain of cellular adaptation" in a way that alters the cellular microenvironment in favor of p73 activation by altering p73-regulatory proteins, e.g. Chk1 activation and dominant negative p73 down-regulation. These findings not only unveil a hitherto unexplained mechanism underlying the functional switchover from p53 to p73, but also validate p73 as a promising and potential target for cancer therapy in the absence of functional p53.
引用
收藏
页码:33104 / 33112
页数:9
相关论文
共 38 条
[1]
Functional association between Wwox tumor suppressor protein and p73, a p53 homolog [J].
Aqeilan, RI ;
Pekarsky, Y ;
Herrero, JJ ;
Palamarchuk, A ;
Letofsky, J ;
Druck, T ;
Trapasso, F ;
Han, SY ;
Melino, G ;
Huebner, K ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (13) :4401-4406
[2]
Induction of p57KIP2 expression by p73β [J].
Bálint, É ;
Phillips, AC ;
Kozlov, S ;
Stewart, CL ;
Vousden, KH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3529-3534
[3]
Chk1 and Chk2 kinases in checkpoint control and cancer [J].
Bartek, J ;
Lukas, J .
CANCER CELL, 2003, 3 (05) :421-429
[4]
DNp73α protects myogenic cells from apoptosis [J].
Belloni, L. ;
Moretti, F. ;
Merlo, P. ;
Damalas, A. ;
Costanzo, A. ;
Blandino, G. ;
Levrero, M. .
ONCOGENE, 2006, 25 (25) :3606-3612
[5]
Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction [J].
Bhattacharyya, Sankar ;
Mandal, Debaprasad ;
Saha, Baisakhi ;
Sen, Gouri Sankar ;
Das, Tanya ;
Sa, Gaurisankar .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (22) :15954-15964
[6]
Tumor-induced oxidative stress perturbs nuclear factorr-κB activity-augmenting tumor necrosis factor-α-mediated T-cell death:: Protection by curcumin [J].
Bhattacharyya, Sankar ;
Mandal, Debaprasad ;
Sen, Gouri Sankar ;
Pal, Suman ;
Banerjee, Shuvomoy ;
Lahiry, Lakshmishri ;
Finke, James H. ;
Tannenbaum, Charles S. ;
Das, Tanya ;
Sa, Gaurisankar .
CANCER RESEARCH, 2007, 67 (01) :362-370
[7]
Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner [J].
Choudhuri, T ;
Pal, S ;
Das, T ;
Sa, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :20059-20068
[8]
Damia G, 2004, CELL CYCLE, V3, P46
[9]
DNA damage induces p53-dependent down-regulation of hCHK1 [J].
Damia, G ;
Sanchez, Y ;
Erba, E ;
Broggini, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :10641-10645
[10]
Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene [J].
Durland-Busbice, S ;
Reisman, D .
LEUKEMIA, 2002, 16 (10) :2165-2167